Advertisement

Topics

Companies Related to "Mitochondrial Protein Offers Potentially Novel Target HER2 Breast" [Most Relevant Company Matches] RSS

10:42 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "Mitochondrial Protein Offers Potentially Novel Target HER2 Breast" found in our extensive corporate database of over 50,000 company records.

Showing "Mitochondrial Protein Offers Potentially Novel Target HER2 Breast" Companies 1–25 of 4,700+

Relevant

Breast Preservation Foundation

The BPF’s mission is to educate women about skin-sparing mastectomies and its advantages for an overall better cosmetic result. Its goal is to inform and empower women to ask more questions before having a potentially disfiguring biopsy, lumpectomy and traditional mastectomy. BPF urges women to insist their breast surgeon recognize the importance of p...


Verne Mendel Medical Corp.

Verne Mendel Medical Corp. is a privately held biopharmaceutical company working on utilizing the highly mature knowledge base of the mitochondrial genome, developed by medical science during the past quarter century. By contrast it may take several decades of further research to reach a comparable level of understanding of the nuclear genome and the proteins it codes for. This knowledge includes...

The Foundation for Mitochondrial Medicine

The Foundation for Mitochondrial Medicine is a 501(c) (3) non-profit organization dedicated to supporting the development of the most promising research and treatments of the many forms of mitochondrial disease. Visit www.mitochondrialdiseases.org for more information.


Abviva, Inc.

Abviva, Inc. is a biomedical company engaged in the innovation, development and commercialization of breast cancer related applications of Mammastatin, a growth inhibitory protein discovered at the University of Michigan Cancer Center that demonstrated anti-breast cancer properties. The discovery was developed into a simple breast cancer diagnostic blood test that demonstrated healthy women have h...

Anaphore Inc.

Anaphore is developing a new class of protein pharmaceuticals to address significant unmet medical needs for patients with serious diseases. The company's Atrimer technology platform originates in tetranectin, a human plasma protein of trivalent structure. Each of the three binding domains comprises five distinct amino-acid loops that can be programmed to bind potently and specifically to virtuall...

Target Discovery, Inc.

Target Discovery discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and management of disease. A growing body of scientific literature shows that protein isoforms correlate more precisely with disease state and patient-specific treatment response than current clinical biomarkers. Most protein isoforms (90%) are made by the body after the protein is produced (post-tra...

GenSight Biologics S.A.

GenSight Biologics S.A. (GenSight) is a clinical-stage biotechnology company discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye, and in the future, of the central nervous system. GenSight’s integrated development includes two core technology platforms, mitochondrial targeting sequence (MTS) and optog...

Protein’eXpert SA

Protein’eXpert is a Contract Research & Manufacturing Organisation providing tailor-made target & therapeutic recombinant protein services.Protein’eXpert combines advanced molecular engineering with low-to-high-throughput manufacturing technologies to discover, optimize, produce and deliver R&D-compatible volumes of soluble proteins from genomic sequences.We strive to bring cost-effective and ...

MitoKor

MitoKor is Pioneering Mitochondrial Medicine™ by developing therapeutic solutions for diseases, based on mitochondrial research. Mitochondria are the self-charging batteries of cells, driving energy production, metabolism, and cellular life and death, as well as participating in other key signaling pathways. Mitochondria also house the "other" human genome, inherited only from the mother. Mitoch...

Target Corp.

Minneapolis-based Target Corporation (NYSE:TGT) serves guests at 1,764 stores across the United States and at Target.com. The company plans to open its first stores in Canada in 2013. In addition, the company operates a credit card segment that offers branded proprietary credit card products. Since 1946, Target has given 5 percent of its income through com...

Serenex

Serenex is an integrated oncology-focused drug discovery and development company. Our mission is to improve the lives of cancer patients by developing proprietary therapeutic and supportive care products. Our most advanced program, SNX-1012, is a product for chemotherapy and radiation-induced oral mucositis. This is scheduled to complete Phase 2 trials in Q1 2007. Our most advanced preclinical-sta...

DOBI Medical International, Inc.

DOBI Medical International, headquartered in Mahwah, NJ, is a technology-based medical device company that is developing a unique and potentially lifesaving means for the improved diagnosis of cancer through the detection of abnormal vascularization changes associated with tumors.Our first application of this technology has been to develop an adjunctive tool to mammography - a key diagnostic imagi...

Agendia, Inc.

Agendia is a privately owned, leading molecular diagnostic company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their complex treatment decisions. Agendia’s breast cancer suite was developed using an unbiased gene selection by analyzing the complete human genome. This includes FDA-cleared MammaPr...

First Warning Systems, Inc.

Temperature readings of breast tissue create Dynamic Thermal Finger Prints (DTFP) which are correlated to dysfunctional circadian genes. Multiple bioinformatics algorithms compare DTFPs to the circadian gene protein profiles to identify breast tissue abnormalities at different stages of development of disturbed breast cancerous cells. FWS’s proprietar...

Kinex Pharmaceuticals, LLC

Kinex Pharmaceuticals is developing next generation anti-cancer drugs that target the molecular basis of disease. The Company uses a proprietary technology platform to generate compounds that inhibit the Protein Kinase and Phosphatase family of proteins.Protein kinases and phosphatases are families of proteins that are intimately involved in transmitting signals across the cell membrane. They cont...

Proteinlounge

Protein Lounge is a leader in the field of system biology. We have developed many interactive web-based databases and software to help the life-scientists understand the complexity of systems biology. Systems biology efforts focus on understanding cellular networks, protein interactions involved in cell signaling, mechanisms of cell survival and apoptosis leading to development or identification o...

Breast Clinic of Memphis

The Breast Clinic of Memphis is focused entirely on treating cancer and other diseases of the breast. Dr. Berry is a consultant and speaker for Susan G. Komen for the Cure. He serves as course instructor for the American College of Surgeons, the American Society of Breast Surgeons, and the H. Lee Moffitt Cancer Center. He is committed to bringing the highe...

PSF biotech AG

PSF biotech (the protein structure factory™) combines state-of-the-art expertise and resources for structure supported drug discovery. Based on our high throughput crystallography platform we offer comprehensive services for lead optimization, structural target validation and characterization of protein drugs. Also we produce active, properly folded protein (high grade) with labels according to ...

Sidec AB

Sidec offers collaborative contract research projects using Protein Tomography(TM) for studying therapeutic antibodies and drug targets in biological systems. The multi-disciplinary team of experts at Sidec can provide a stronger IP strategy and proven product differentiation to the bio-pharmaceutical industry. Protein Tomography(TM) provides our partners with unique visual guidance at the mol...

Susan G. Komen for the Cure and Canadian Breast Cancer Foundation

The Canadian Breast Cancer Foundation was founded in 1986 by a group of volunteers and has become the leading national volunteer-based organization in Canada dedicated to creating a future without breast cancer. The Canadian Breast Cancer Foundation has invested over $170 million since its inception to collaboratively fund, support and advocate for relevan...

Primorigen Biosciences LLC

Primorigen develops, manufactures, and distributes laboratory products for cell charaterization, quantitative protein detection, and basic biochemical research. These products include thin-film nitrocellulose slides and kits, well-characterized monoclonal antibodies, target protein standards, and other laboratory reagents. The company is developing new multiplexed immunoarray products for severa...

Vividion Therapeutics, Inc.

Conventional drug discovery is target-centric; a compound library is screened using a target-specific assay and high-affinity binding ligands are optimized to develop a drug candidate. This approach is limited, as research is performed in artificial systems that fail to account for native protein structure, context and function. Further, conventional targe...

Aurora Imaging Technology Inc.

Aurora Imaging Technology Inc. is a private company based in North Andover, Mass. committed to the fight against breast cancer. Aurora strives to manufacture the highest quality and most cost-effective breast MRI solutions, and partners with a growing number of the world's finest breast care centers to provide the ultimate in the detection, diagnosis, biop...

Arizona Breast Cancer Specialists

Arizona Breast Cancer Specialists, based in Scottsdale, Ariz., is the first radiation practice in the world exclusively dedicated to treating women with breast cancer. The equipment, devices, and treatment techniques used at Arizona Breast Cancer Specialists have been selected for the ability to maximize precision and effectiveness while minimizing the col...

Breast Care

Our inspiration for creating a comprehensive breast care center was based on our observation that the care for women with breast problems was fragmented. There were delays in diagnosis, delays in treatment, and a lack of communication among doctors and between the doctors and their patients. We envisioned a revolutionary new approach to breast care. We concluded that breast problems should be trea...


More From BioPortfolio on "Mitochondrial Protein Offers Potentially Novel Target HER2 Breast"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks